International Generic and Biosimilar Medicines Association (IGBA)

news

ATOM partnership seeks to increase access to cancer medicines in LLMICs

23 May 2022 | By Sarah Wills (European Pharmaceutical Review)

A unique partnership, the Access to Oncology Medicines (ATOM) Coalition, has been established to ensure sustainable access to cancer medicines in low- and lower middle-income countries (LLMICs) in the long-term.

article

Six major disruptors for the generics and biosimilars market

3 September 2021 | By Hannah Balfour (European Pharmaceutical Review)

In this article, EPR's Hannah Balfour outlines six factors that could significantly challenge the generics and biosimilars market in the next decade.

news

WHO launches Access to COVID-19 Tools Accelerator

30 April 2020 | By Victoria Rees (European Pharmaceutical Review)

The World Health Organization (WHO) has launched its Access to COVID-19 Tools Accelerator, a collaboration to progress the development of coronavirus vaccines and therapeutics.